These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
111 related items for PubMed ID: 19597030
1. Higher incidence of relapse with peripheral blood rather than marrow as a source of stem cells in adults with acute myelocytic leukemia autografted during the first remission. Gorin NC, Labopin M, Blaise D, Reiffers J, Meloni G, Michallet M, de Witte T, Attal M, Rio B, Witz F, Fouillard L, Willemze R, Rocha V, Acute Leukemia Working Party of the European Cooperative Group for Blood and Marrow Transplantation. J Clin Oncol; 2009 Aug 20; 27(24):3987-93. PubMed ID: 19597030 [Abstract] [Full Text] [Related]
4. The role of stem cell source in autologous hematopoietic stem cell transplantation for patients with myelodysplastic syndromes. de Witte T, Brand R, van Biezen A, Delforge M, Biersack H, Or R, Meloni G, Bandini B, Sierra J, Kroger N, Gratwohl A, Niederwieser D, MDS subcommittee of the EBMT Chronic Leukemia Working Party. Haematologica; 2006 Jun 20; 91(6):750-6. PubMed ID: 16769576 [Abstract] [Full Text] [Related]
5. Impact of conditioning regimen in allogeneic hematopoetic stem cell transplantation for children with acute myelogenous leukemia beyond first complete remission: a pediatric blood and marrow transplant consortium (PBMTC) study. Sisler IY, Koehler E, Koyama T, Domm JA, Ryan R, Levine JE, Pulsipher MA, Haut PR, Schultz KR, Taylor DS, Frangoul HA. Biol Blood Marrow Transplant; 2009 Dec 20; 15(12):1620-7. PubMed ID: 19896086 [Abstract] [Full Text] [Related]
6. Hematopoietic stem cell transplantation for adults with acute promyelocytic leukemia in the ATRA era: a survey of the European Cooperative Group for Blood and Marrow Transplantation. Sanz MA, Labopin M, Gorin NC, de la Rubia J, Arcese W, Meloni G, Bacigalupo A, Alessandrino P, Carreras E, Iriondo A, Novitzky N, Jacobs P, Bandini G, Lo-Coco F, Frassoni F, Rocha V, Acute Leukemia Working Party (ALWP) of European Cooperative Group for Blood and Marrow Transplantation (EBMT). Bone Marrow Transplant; 2007 Apr 20; 39(8):461-9. PubMed ID: 17322930 [Abstract] [Full Text] [Related]
7. Autologous stem cell transplantation for therapy-related acute myeloid leukemia and myelodysplastic syndrome. Kröger N, Brand R, van Biezen A, Cahn JY, Slavin S, Blaise D, Sierra J, Zander A, Niederwieser D, de Witte T, Myelodysplastic Syndromes Subcommittee of The Chronic Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT). Bone Marrow Transplant; 2006 Jan 20; 37(2):183-9. PubMed ID: 16299545 [Abstract] [Full Text] [Related]
8. Retrospective evaluation of autologous bone marrow transplantation vs allogeneic bone marrow transplantation from an HLA identical related donor in acute myelocytic leukemia. A study of the European Cooperative Group for Blood and Marrow Transplantation (EBMT). Gorin NC, Labopin M, Fouillard L, Meloni G, Frassoni F, Iriondo A, Brunet Mauri S, Goldstone AH, Harousseau JL, Reiffers J, Esperou-Bourdeau H, Gluckman E. Bone Marrow Transplant; 1996 Jul 20; 18(1):111-7. PubMed ID: 8832003 [Abstract] [Full Text] [Related]
11. Bone marrow or peripheral blood stem cell transplantation from unrelated donors in adult patients with acute myeloid leukaemia, an Acute Leukaemia Working Party analysis in 2262 patients. Ringdén O, Labopin M, Beelen DW, Volin L, Ehninger G, Finke J, Greinix HT, Kyrcz-Krzemien S, Bunjes D, Brinch L, Niederwieser D, Arnold R, Mohty M, Rocha V, Acute Leukaemia Working Party of European Group for Blood and Marrow Transplantation (EBMT). J Intern Med; 2012 Nov 20; 272(5):472-83. PubMed ID: 22519980 [Abstract] [Full Text] [Related]
13. Allogeneic hematopoietic cell transplantation in children with relapsed acute lymphoblastic leukemia isolated to the central nervous system. Harker-Murray PD, Thomas AJ, Wagner JE, Weisdorf D, Luo X, DeFor TE, Verneris MR, Dusenbery KE, MacMillan ML, Tolar J, Baker KS, Orchard PJ. Biol Blood Marrow Transplant; 2008 Jun 20; 14(6):685-92. PubMed ID: 18489994 [Abstract] [Full Text] [Related]
14. Autologous blood stem cell transplantation for acute myeloblastic leukemia in first complete remission. Intensification therapy before transplantation does not prolong disease-free survival. de la Rubia J, Sanz GF, Martín G, Martínez J, Cervera J, Solves P, Jiménez C, Arnao M, Vicente A, Jarque I, Sempere A, Sanz MA. Haematologica; 1999 Feb 20; 84(2):125-32. PubMed ID: 10091410 [Abstract] [Full Text] [Related]
15. IPSS poor-risk karyotype as a predictor of outcome for patients with myelodysplastic syndrome following myeloablative stem cell transplantation. Nevill TJ, Shepherd JD, Sutherland HJ, Abou Mourad YR, Lavoie JC, Barnett MJ, Nantel SH, Toze CL, Hogge DE, Forrest DL, Song KW, Power MM, Nitta JY, Dai Y, Smith CA. Biol Blood Marrow Transplant; 2009 Feb 20; 15(2):205-13. PubMed ID: 19167680 [Abstract] [Full Text] [Related]
16. Higher mortality after allogeneic peripheral-blood transplantation compared with bone marrow in children and adolescents: the Histocompatibility and Alternate Stem Cell Source Working Committee of the International Bone Marrow Transplant Registry. Eapen M, Horowitz MM, Klein JP, Champlin RE, Loberiza FR, Ringdén O, Wagner JE. J Clin Oncol; 2004 Dec 15; 22(24):4872-80. PubMed ID: 15520055 [Abstract] [Full Text] [Related]
17. Allogeneic blood stem cell and bone marrow transplantation for acute myelogenous leukemia and myelodysplasia: influence of stem cell source on outcome. Russell JA, Larratt L, Brown C, Turner AR, Chaudhry A, Booth K, Woodman RC, Wolff J, Valentine K, Stewart D, Ruether JD, Ruether BA, Klassen J, Jones AR, Gyonyor E, Egeler M, Dunsmore J, Desai S, Coppes MJ, Bowen T, Anderson R, Poon MC. Bone Marrow Transplant; 1999 Dec 15; 24(11):1177-83. PubMed ID: 10642805 [Abstract] [Full Text] [Related]
18. Similar survival following HLA-identical sibling transplantation for standard indication in children with haematologic malignancies: a single center comparison of mobilized peripheral blood stem cell with bone marrow transplantation. Meisel R, Enczmann J, Balzer S, Bernbeck B, Kramm C, Schönberger S, Sinha K, Tröger A, Wernet P, Göbel U, Laws HJ, Dilloo D. Klin Padiatr; 2005 Dec 15; 217(3):135-41. PubMed ID: 15858704 [Abstract] [Full Text] [Related]
19. Reduced intensity conditioning compared with myeloablative conditioning using unrelated donor transplants in patients with acute myeloid leukemia. Ringdén O, Labopin M, Ehninger G, Niederwieser D, Olsson R, Basara N, Finke J, Schwerdtfeger R, Eder M, Bunjes D, Gorin NC, Mohty M, Rocha V. J Clin Oncol; 2009 Sep 20; 27(27):4570-7. PubMed ID: 19652066 [Abstract] [Full Text] [Related]
20. Patients with acute lymphoblastic leukaemia allografted with a matched unrelated donor may have a lower survival with a peripheral blood stem cell graft compared to bone marrow. Garderet L, Labopin M, Gorin NC, Polge E, Fouillard L, Ehninger GE, Ringden O, Finke J, Tura S, Frassoni F. Bone Marrow Transplant; 2003 Jan 20; 31(1):23-9. PubMed ID: 12621503 [Abstract] [Full Text] [Related] Page: [Next] [New Search]